An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Diane Hershock, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hopital Europeen Georges Pompidou (hegp)
Paris, France
- Hospital Saint Louis
Paris, France
- Institut Gustave Roussy
Villejuif, France
- Istituto Tumori Giovanni Paolo Ii Irccs Ospedale Oncologico Bari
Bari, Italy
- L Azienda Ospedaliero-Universitaria Di Bologna Policlinico S. Orsola - Malpighi
Bologna, Italy
- Istituto Di Ricovero E Cura A Carattere Scientifico (irccs) Ospedale San Raffaele
Milan, Italy
- Universita Campus Bio Medico Di Roma
Roma, Italy
- Azienda Ospedaliera Universitaria Integrata Verona (ospedale Borgo Roma)
Verona, Italy
- University of Iowa
Iowa City, Iowa, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Ohio State University Medical Center Division of H
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jan 2022
- Primary completion
- 29 Jan 2024
- Completion
- 29 Jan 2024
- Last update posted
- 30 Oct 2025
- Registered enrollment
- 30
- Registry id
- NCT04586244
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.